Cargando…

Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation

Pneumococcal disease is a potentially fatal bacterial infection that is vaccine-preventable. Malaysia has yet to adopt a pneumococcal conjugate vaccine (PCV) into its national immunization program (NIP). In 2016, pneumonia was the 3(rd) leading cause of death in children under five in Malaysia, acco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafie, Asrul Akmal, Ahmad, Norazah, Naidoo, Jerusha, Foo, Chee Yoong, Wong, Callix, Pugh, Sarah, Tan, Kah Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482775/ https://www.ncbi.nlm.nih.gov/pubmed/31951782 http://dx.doi.org/10.1080/21645515.2019.1701911

Ejemplares similares

Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
por: Ghia, Canna J., et al.
Publicado: (2021)

Impact of targeted educational intervention towards public knowledge and perception of antibiotic use and resistance in the state of Perak, Malaysia
por: Thong, Kah Shuen, et al.
Publicado: (2021)

Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
por: Ghia, Canna J., et al.
Publicado: (2021)

The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study
por: Yeo, Hui Yee, et al.
Publicado: (2018)

Economic evaluation of pneumococcal conjugate vaccination in The Gambia
por: Kim, Sun-Young, et al.
Publicado: (2010)

Estimating clinical and economic burden of pneumococcal meningitis in Malaysia using Casemix data
por: Maimaiti, Namaitijiang, et al.
Publicado: (2012)

Using a dynamic adherence Markov model to assess the efficiency of Respiratory Medication Therapy Adherence Clinic (RMTAC) on asthma patients in Malaysia
por: Yong, Yee Vern, et al.
Publicado: (2018)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)

Tracing contacts of TB patients in Malaysia: costs and practicality
por: Atif, Muhammad, et al.
Publicado: (2012)

Economic Evaluation of Oral Cancer Screening Programs: Review of Outcomes and Study Designs
por: Raman, Sivaraj, et al.
Publicado: (2023)

Economic evaluation of enhanced asthma management: a systematic review
por: Yong, Yee V., et al.
Publicado: (2014)

Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India
por: Megiddo, Itamar, et al.
Publicado: (2018)

Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2014)

Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Economic Evaluation of Childhood 7-Valent Pneumococcal Conjugate Vaccination in Korea
por: Sohn, Hyun Soon, et al.
Publicado: (2010)

Rare disease in Malaysia: Challenges and solutions
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)

Determination of chest x-ray cost using activity based costing approach at Penang General Hospital, Malaysia
por: Atif, Muhammad, et al.
Publicado: (2012)

Correction: Rare disease in Malaysia: Challenges and solutions
por: Shafie, Asrul Akmal, et al.
Publicado: (2022)

Assessment of medication adherence and the costs associated with a calendar blister pack intervention among hypertensive patients in Malaysia: A randomized controlled trial
por: Tan, Bee Ying, et al.
Publicado: (2017)

Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2020)

Health-related quality of life among children with transfusion-dependent thalassemia: A cross-sectional study in Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
por: Gourzoulidis, George, et al.
Publicado: (2023)

Resource utilization pattern and cost of tuberculosis treatment from the provider and patient perspectives in the state of Penang, Malaysia
por: Atif, Muhammad, et al.
Publicado: (2014)

Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia
por: Atif, Muhammad, et al.
Publicado: (2014)

Consensus among healthcare stakeholders on a collaborative medication therapy management model for chronic diseases in Malaysia; A Delphi study
por: Mubarak, Naeem, et al.
Publicado: (2019)

Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia
por: Aljunid, Syed, et al.
Publicado: (2011)

Estimating the Clinical and Economic Impact of Maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico
por: Wasserman, Matt, et al.
Publicado: (2017)

The economic burden of schizophrenia in Malaysia
por: Teoh, Siew Li, et al.
Publicado: (2017)

The economically important thrips from Malaysia, with a key to species (Thysanoptera, Thripinae)
por: Ng, Yong Foo, et al.
Publicado: (2018)

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea
por: Choi, Eun Hwa, et al.
Publicado: (2011)

Estimating the economic burden of influenza on the older population in Malaysia
por: Mad Tahir, Nur Syazana, et al.
Publicado: (2023)

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis
por: Rozenbaum, Mark H, et al.
Publicado: (2012)

Knowledge, Attitudes and Practices toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in Countries from Latin America and Asia Pacific: A Cross-Sectional Study (GEMKAP)
por: Shafie, Asrul Akmal, et al.
Publicado: (2023)

Household Catastrophic Health Expenditure from Oral Potentially Malignant Disorders and Oral Cancer in Public Healthcare of Malaysia
por: Raman, Sivaraj, et al.
Publicado: (2022)

Building intentions with the theory of planned behaviour: a qualitative assessment of salient beliefs about pharmacy value added services in Malaysia
por: Tan, Christine Liang Hoay, et al.
Publicado: (2015)

Willingness to pay for a pharmacist’s dispensing service: a cross-sectional pilot study in the state of Penang, Malaysia
por: Shafie, Asrul A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ii9q2vtuju6edlcm2vc7pndb47